// App-Quantinova.ai

2265 : An integrated analysis of gene mutations and gene sets for predicting paclitaxel response in lung adenocarcinoma

Researchers

Presenter

  • Chia-Yu Huang

Principal Investigators

  • Yu-Chiao Chiu

  • Tzu-Pin Lu

  • Liang-Chuan Lai

  • Mong-Hsun Tsai

  • Tzu-Hung Hsiao

  • Eric Y. Chuang

Medical Centers

  • Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.

  • Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan

  • 9Graduate Institute of Physiology, National Taiwan University, Taipei, Taiwan

  • Institute of Biotechnology, National Taiwan University, Taipei, Taiwan

  • Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Paclitaxel

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved